Literature DB >> 20797423

C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells.

Mahua Choudhury1, Ishtiaq Qadri, Shaikh Mizanoor Rahman, Jill Schroeder-Gloeckler, Rachel C Janssen, Jacob E Friedman.   

Abstract

Diabetes and obesity are associated with activation of endoplasmic reticulum (ER) stress; however a direct link between ER stress and increased hepatic gluconeogenesis remains unclear. Here we show that ER stress triggers a significant increase in expression of CCAAT/enhancer-binding protein (C/EBPβ) and phosphorylated CREB together with reduced phospho-AMP-activated protein kinase (pAMPK) in hepatoma cells. ER stress contributed to transcriptional activation of the gluconeogenic phosphoenolpyruvate carboxykinase (PEPCK) promoter in Huh7 and HepG2 cells via cAMP binding motif (CRE site). Chromatin immunoprecipitation assays demonstrate that C/EBPβ is recruited to the PEPCK promoter during ER stress and is reversed by pre-treatment with a JNK inhibitor that relieves ER stress. C/EBPβ but not pCREB was suppressed by the AMPK-activator AICAR or constitutively active AMPK, while dominant negative AMPK increased C/EBPβ expression. These data suggest that ER stress triggers suppression of AMPK while increasing C/EBPβ and pCREB expression which activates PEPCK gene transcription. Understanding how ER stress suppresses AMPK activation and increases C/EBPβ expression could lead to a potentially novel pathway for treatment of diabetes.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797423      PMCID: PMC2981635          DOI: 10.1016/j.mce.2010.08.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  47 in total

Review 1.  Tripartite management of unfolded proteins in the endoplasmic reticulum.

Authors:  K Mori
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

2.  Regulation of hepatic lipogenesis by the transcription factor XBP1.

Authors:  Ann-Hwee Lee; Erez F Scapa; David E Cohen; Laurie H Glimcher
Journal:  Science       Date:  2008-06-13       Impact factor: 47.728

3.  AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.

Authors:  Nanao Horike; Hideyuki Sakoda; Akifumi Kushiyama; Hiraku Ono; Midori Fujishiro; Hideaki Kamata; Koichi Nishiyama; Yasunobu Uchijima; Yukiko Kurihara; Hiroki Kurihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

4.  CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.

Authors:  Jill M Schroeder-Gloeckler; Shaikh Mizanoor Rahman; Rachel C Janssen; Liping Qiao; Jianhua Shao; Michael Roper; Stephanie J Fischer; Erin Lowe; David J Orlicky; James L McManaman; Carol Palmer; William L Gitomer; Wan Huang; Robert M O'Doherty; Thomas C Becker; Dwight J Klemm; Dalan R Jensen; Leslie K Pulawa; Robert H Eckel; Jacob E Friedman
Journal:  J Biol Chem       Date:  2007-03-26       Impact factor: 5.157

5.  Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype.

Authors:  Duygu Sag; David Carling; Robert D Stout; Jill Suttles
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice.

Authors:  Seiichi Oyadomari; Heather P Harding; Yuhong Zhang; Miho Oyadomari; David Ron
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

7.  Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.

Authors:  Mahua Choudhury; Shivendra D Shukla
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

8.  Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.

Authors:  N Arai; H Masuzaki; T Tanaka; T Ishii; S Yasue; N Kobayashi; T Tomita; M Noguchi; T Kusakabe; J Fujikura; K Ebihara; M Hirata; K Hosoda; T Hayashi; H Sawai; Y Minokoshi; K Nakao
Journal:  Endocrinology       Date:  2007-08-16       Impact factor: 4.736

9.  Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).

Authors:  Ishtiaq Qadri; Ling-Jia Hu; Mieko Iwahashi; Subhi Al-Zuabi; Linda C Quattrochi; Francis R Simon
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-29       Impact factor: 4.219

10.  Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.

Authors:  Yi Li; Elena Bevilacqua; Calin-Bogdan Chiribau; Mithu Majumder; Chuanping Wang; Colleen M Croniger; Martin D Snider; Peter F Johnson; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2008-06-11       Impact factor: 5.157

View more
  19 in total

Review 1.  The endoplasmic reticulum stress response and diabetic kidney disease.

Authors:  Robyn Cunard; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-23

2.  Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice.

Authors:  James R Sowers; Javad Habibi; Annayya R Aroor; Yan Yang; Guido Lastra; Michael A Hill; Adam Whaley-Connell; Frederic Jaisser; Guanghong Jia
Journal:  Metabolism       Date:  2019-07-11       Impact factor: 8.694

3.  Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes.

Authors:  Bing M Liao; Sophie A McManus; William E Hughes; Carsten Schmitz-Peiffer
Journal:  Mol Endocrinol       Date:  2016-02-17

Review 4.  Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.

Authors:  Tamhida Masi; Bhoomika M Patel
Journal:  Pharmacol Rep       Date:  2020-11-03       Impact factor: 3.024

5.  Stable conditional expression and effect of C/ebpβ-LIP in adipocytes using the pSLIK system.

Authors:  Cristina L Esteves; Val Kelly; Valérie Bégay; Simon G Lillico; Achim Leutz; Jonathan R Seckl; Karen E Chapman
Journal:  J Mol Endocrinol       Date:  2013-06-04       Impact factor: 5.098

6.  AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPβ/E3 Ubiquitin Ligase Signaling pathway.

Authors:  Vishal Kothari; Jeganathan Ramesh Babu; Suresh T Mathews
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

7.  Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.

Authors:  Tomokazu Matsuda; Hiroaki Takahashi; Yusuke Mieda; Shinobu Shimizu; Takeshi Kawamoto; Yuki Matsuura; Tomoko Takai; Emi Suzuki; Ayumi Kanno; Maki Koyanagi-Kimura; Shun-ichiro Asahara; Alberto Bartolome; Norihide Yokoi; Hiroshi Inoue; Wataru Ogawa; Susumu Seino; Yoshiaki Kido
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

8.  Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Authors:  Tao Fang; Meiling Cui; Ji Sun; Chao Ge; Fangyu Zhao; Lin Zhang; Hua Tian; Lixing Zhang; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Hong Li; Jinjun Li
Journal:  Oncotarget       Date:  2015-06-30

Review 9.  AMPK, insulin resistance, and the metabolic syndrome.

Authors:  Neil B Ruderman; David Carling; Marc Prentki; José M Cacicedo
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α.

Authors:  Hiroshi Matsuoka; Akiho Shima; Daisuke Kuramoto; Daisuke Kikumoto; Takashi Matsui; Akihiro Michihara
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.